Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2026 Oct 24 · Gędek A, Modrzejewski S, Polański K et
MH
By Maren Holt · Senior Reporter, GLP-1
From the source
Read at pubmed.ncbi.nlm.nih.govEfficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2026 Oct 24 · Gędek A, Modrzejewski S, Polański K et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42925811/
